5 results about "Increased body temperature" patented technology

A method and apparatus for manipulating a temperature set-point of a human or homeothermic-animal for increasing or decreasing the body temperature above or below the prevailing body temperature for therapeutic purposes. The method includes the steps of warming or cooling sphenoid sinuses externally resulting in manipulation of the temperature of the pituitary gland which in turn results in manipulation of the body-temperature set-point and the body temperature manipulates accordingly to the new temperature set-point. A heat exchange medium can be used to warm or cool sphenoid sinuses and thus the pituitary gland. The heat exchange fluid can be liquid, or gas maintained at a predetermined temperature. Alternatively, a temperature-controlled probe can be used that upon contact with the sphenoid sinuses provides for the heat exchange.

A method and apparatus for manipulating a temperature set-point of a human or homeothermic-animal for increasing or decreasing the body temperature above or below the prevailing body temperature for therapeutic purposes. The method includes the steps of warming or cooling sphenoid sinuses remotely resulting in manipulation of the temperature of the pituitary gland without manipulation of the hypothalamus temperature which in turn results in manipulation of the body-temperature set-point and the body temperature manipulates accordingly to the new temperature set-point. A heat exchange medium can be used to warm or cool sphenoid sinuses and thus the pituitary gland. The heat exchange fluid can be liquid, or gas maintained at a predetermined temperature. Alternatively, a temperature-controlled probe can be used that upon contact with the sphenoid sinuses provides for the heat exchange.

The present application relates to the field of medicinal chemistry and pharmacotherapy, in particular to a phenylpiperazine compound or a pharmaceutically acceptable salt thereof, a preparation method and use thereof in the preparation of analgesic drugs or drugs for treating pain, wherein the phenylpiperazine compound or the pharmaceutically acceptable salt thereof has the following structure: the phenylpiperazine compound has obvious inhibitory activity on TRPV1, can obviously inhibit the pain response, and has no side effect of body temperature rise.

A system comprising a toilet seat and an evaluation unit (20), wherein a sensor system (10) for detecting a plurality of vital parameters is integrated into the toilet seat, and the toilet seat has a technology box (4) in which a control unit for controlling the sensor system (10) and for the individualized detection of the measurement data detected by the sensor system (10), in particular vital parameters, and a communication interface for receiving and transmitting data are accommodated, wherein the communication interface is in data communication with the evaluation unit (20), which is designed with a diagnostic unit configured to evaluate the detected vital parameters on the basis of databases stored in the evaluation unit (20) or connected via a further communication interface, and to output corresponding information or recommendations to the user or a unit operating the toilet seat (1) via an output interface, characterized in that the sensors (10) sensors for recording an ECG, the Body temperature, blood oxygen saturation and pulse rate, and wherein the evaluation unit (20) is designed with an artificial intelligence (AI) which is designed to output a finding according to a class based on the recorded measurement data, The AI ​​issues a Class 1 finding if a normal ECG, normal oxygen saturation, normal body temperature, normal weight and normal BMI are detected, the AI ​​issues a Class 2 finding if an increased heart rate, reduced oxygen saturation, elevated temperature, increased weight and / or abnormal BMI is detected, the AI ​​issues a Class 3 finding if a cardiac arrhythmia or atrial fibrillation, or low oxygen saturation, high temperature, significantly excessive weight or BMI is detected, The AI ​​is designed to detect a certain trend by comparing it with the user's existing data, indicating an improvement or deterioration in vital signs, and the AI ​​can determine whether a medication is working.

The invention discloses a coptis chinensis-radix scutellariae soluble powder for preventing and treating a chicken wind-heat affecting lung syndrome and application thereof. According to the technical scheme, the lianhua-radix scutellariae soluble powder is administrated to sick chickens in a drinking water administration mode, 1-4 g, preferably 2 g, of the lianhua-radix scutellariae soluble powder is added to each liter of drinking water, and the lianhua-radix scutellariae soluble powder is continuously administrated for 5 days and is administrated once a day. The medicine is used for treating the chicken wind-heat invading lung syndrome caused by infectious bronchitis virus infection, and clinical symptoms comprise depressed spirit, body temperature rise exceeding 41.5 DEG C, cough and sneezing, runny nose and tracheal rale, inappetence and drinking water increase and the like. The Maxingshigan granule has the beneficial effects that when 2g of the Maxingshigan granule is added into each liter of drinking water, the total effective rate reaches 90.00% and the cure rate is 66.67% after the Maxingshigan granule is treated for 5 days, and the Maxingshigan granule is obviously superior to the 76.67% total effective rate and the 43.33% cure rate of the existing Maxingshigan granule; by increasing the content of CD3 +, CD3 + CD4 + and CD3 + CD8 + T lymphocytes in peripheral blood of the sick chicken, the immune function of the body is enhanced; the drug administration is convenient, and the method is suitable for large-scale breeding application.